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LETTER TO THE EDITOR
Serum methotrexate in childhood ALL
Sir - With respect to the article entitled 'The Influence of
Serum Methotrexate Concentrations and Drug Dosage on
Outcome In Childhood Acute Lymphoblastic Leukaemia', we
believe basic pharmacokinetic principles have not been cor-
rectly applied.
The apparent lack of correlation described therein may be
due to the method used to calculate methotrexate clearance.
Following an intra-venous bolus, drug clearance is calculated
by dividing the total dose administered by the AUC inte-
grated to infinity (Goodman & Gilman, 1980; Greenblatt &
Koch-Wester, 1975a,b). It is not acceptable to use areas
integrated to less than infinity to calculate clearance. The
formulae derived for calculating clearance are based on the
premise that integration occurs to infinity and not any
predefined time point. However, another complicating factor
is that plasma samples should have been collected for app-
roximately 40 and not the 24 h performed in the study to
obtain a 95% confidence limits of the estimate of the Area
under the Curve to infinity and Beta half-life (Rowland &
Tozer, 1989). Lastly, the concept of median plasma
methotrexate concentration is not useful for correlation of
pharmacokinetic parameters with response.
As a result of these errors no true comment about the
relationship of pharmacokinetic parameters and response can
be made. It is a pity that at a time when a number of groups
(including ourselves) are finding important correlations
between the pharmacology of cytotoxics, response and tox-
icity that incorrectly calculated parameters are used to dis-
credit the role of pharmacokinetics in oncology.
Yours etc,
Walter Cosolo
Medical Oncologist
Head, Palliative Care Unit
Jim Siderov
Oncology Pharmacist
John Zalcberg
Director, Medical Oncology
Heidelberg Repatriation Hospital
Banksia Street,
Heidelberg West,
Victoria 3081
Australia
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